missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30154601

DEP-1/CD148 Antibody (261922), CoraFluor™ 1, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB19341CL1

Product Code. 30154601

  • € 1035.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

DEP-1/CD148 Monoclonal antibody specifically detects DEP-1/CD148 in Human samples. It is validated for Flow Cytometry,CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DEP-1/CD148
Monoclonal
CoraFluor 1
CD148, CD148 antigen, Density-enhanced phosphatase 1, DEP-1, DEP1EC 3.1.3.48, HPTP eta, HPTPeta, human density enhanced phosphatase-1, protein tyrosine phosphatase, receptor type, J, protein tyrosine phosphatase, receptor type, J polypeptide, Protein-tyrosine phosphatase eta, Protein-tyrosine phosphatase receptor type J, receptor-type tyrosine-protein phosphatase eta, R-PTP-eta, R-PTP-J, SCC1, susceptibility to colon cancer 1, mouse, homolog of
E. coli-derived recombinant human DEP-1/CD148, Arg997-Ala1337, Accession # Q12913
0.1 mL
Protein Phosphatase
5795
Store at 4°C in the dark. Do not freeze.
IgG2b
Flow Cytometry, CyTOF
261922
PBS
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.